Fact CheckerSign in

NCT03962127Active, not recruiting

MIDNOR-STROKE- a Long Term Follow-up Study of Patients With First Ever Ischemic Stroke in Central Norway

MIDNOR-STROKE A Prospective Observation Study of a Cohort of 800 Patients With First Ever Ischemic Stroke in Central Norway

Source: ClinicalTrials.gov · Last updated 13 Aug 2026

Brief summary (registry, in English)

Annually 13000 Norwegians experience an ischemic stroke. The number of stroke is anticipated to increase with 50% within 2030 due to a growing number of elderly. Many of them will have severe function deficits and reduced quality of life. The investigators have established a cohort consisting of 800 patients with first time ischemic stroke treated at hospitals in Central Norway. The investigators want to study the incidence and prognostic markers for death, recurrent stroke and severe functional deficits during a period of 10 years after the initial ischemic stroke. The investigators want to focus on the impact of physical functioning, the level of physical activity and use of medication for secondary prevention on the incidence of death, recurrent stroke and severe functional deficits. The investigators are especially interested in the importance of fulfilling the treatment targets for blood pressure and cholesterol and the importance of smoking cessation in stroke survivors. Our objective is to improve todays stroke treatment and achieve a more efficient use of the health resources in order to increase survival after stroke maintaining a good physical and psychological function and quality of life.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
800 (actual)
First submitted
17 May 2019
Start date
1 May 2015
Primary completion date
Aug 2026
Lead sponsor
Norwegian University of Science and Technology
Diseases
Stroke
NCT number
NCT03962127

What you commit to

  • Study type: Observational
  • Participants enrolled: 800
  • From 1 May 2015 to the primary completion date, Aug 2026
  • 8 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Significant physical disabilities prior to stroke (defined as Modified Rankin ≥5).

Other illness

  • Focal neurological symptoms turned out to be not stroke-related

Who the study is looking for

  • Cerebral infarction according to ICD-10 CM code I63
  • \> 18 years of age
  • First time stroke resident in Central-Norway
  • Recruited within a time frame of 7 days of hospital admission.

Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (8)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ålesund sykehus
Coordinator of this site? Confirm its status
ÅlesundNorwayUnknown status
Kristiansund Sykehus
Coordinator of this site? Confirm its status
KristiansundNorwayUnknown status
Levanger sykehus
Coordinator of this site? Confirm its status
LevangerNorwayUnknown status
Molde Sykehus
Coordinator of this site? Confirm its status
MoldeNorwayUnknown status
Namsos Sykehus
Coordinator of this site? Confirm its status
NamsosNorwayUnknown status
Orkdal Sykehus
Coordinator of this site? Confirm its status
OrkangerNorwayUnknown status
St Olavs Hospital
Coordinator of this site? Confirm its status
TrondheimNorwayUnknown status
Volda Sykehus
Coordinator of this site? Confirm its status
VoldaNorwayUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.